Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2009 | 2010 | 2011 | 2012 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $64.3M | $73.8M | $88.8M | $94.5M | $83.6K | $71.5K | $67.6K | $65.3K |
| Cost of revenue | $41.1M | $43.9M | $50.1M | $52.5M | $0 | $70.2K | $49.0K | $50.9K |
| Gross profit | $23.3M | $30.0M | $38.8M | $42.1M | $83.6K | $1.4K | $18.6K | $14.4K |
| Gross margin | 36.2% | 40.6% | 43.6% | 44.5% | 100.0% | 1.9% | 27.6% | 22.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $13.6M | $17.3M | $17.7M | $24.1M | −$5.1K | $1.4K | −$9.3K | −$11.9K |
| EBITDA | $14.7M | $19.9M | $20.1M | $25.9M | −$5.1K | $1.4K | −$9.3K | −$11.9K |
| Net income | $10.4M | $13.4M | $13.5M | $17.5M | −$5.1K | $1.4K | −$9.3K | −$11.9K |
| Net margin | 16.2% | 18.2% | 15.2% | 18.5% | -6.1% | 1.9% | -13.8% | -18.2% |
| EPS (diluted) | 4.91 | 5.79 | 5.36 | 6.78 | -0.00 | 0.00 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
KALI INC
No one on the platform currently holds KALY.
No tracked institution reports a position in KALY as of their last filing.
No one on the platform has traded KALY yet.
| $72413 |
| — |
| FLHLFFilament Health Corp. | $0.00 | +0.00% | $26179 | — |
| GMVDFG Medical Innovations Holdings Ltd | $0.00 | +0.00% | $25992 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.